Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Fuji Chemical Granted Inflammation Patent For Astaxanthin
Fuji Chemical Industry Co., Ltd. has been granted U.S. Patent No. 7,078,040, which involves inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxnathin.
- Fortitech South America Adds Staff to Address Rapid Premix Sales Growth
Fortitech South America has increased its workforce by hiring Rafael Leite as its newest regional sales manager. Leite, who will focus on all Spanish-speaking countries in South America
- Fortitech South America Adds Staff to Address Rapid Premix Sales Growth
Fortitech South America has increased its workforce by hiring Rafael Leite as its newest regional sales manager. Leite, who will focus on all Spanish-speaking countries in South America
- NSF Vice President Named Adjunct Assistant Professor for Michigan State University
NSF Vice President Named Adjunct Assistant Professor for MSU’s Food Science and Human Nutrition Department
- NSF Vice President Named Adjunct Assistant Professor for Michigan State University
NSF Vice President Named Adjunct Assistant Professor for MSU’s Food Science and Human Nutrition Department
- Lifeway Foods Acquires Helios Kefir
Company announces the acquisition of Helios Nutrition Limited, its top competitor in the kefir market with a #2 overall market share and a #1 position in the organic category.
- Lifeway Foods Acquires Helios Kefir
Company announces the acquisition of Helios Nutrition Limited, its top competitor in the kefir market with a #2 overall market share and a #1 position in the organic category.
- NBTY Reports Third Quarter Results
Company reports net sales of $475 million, including $24 million generated by Solgar, compared to net sales of $439 million for the fiscal third quarter prior year, with net income of $30 million, or $0.43 per diluted share, compared to $16 million, or $0.23 per diluted share, for the fiscal third quarter ended June 30, 2005.
- NBTY Reports Third Quarter Results
Company reports net sales of $475 million, including $24 million generated by Solgar, compared to net sales of $439 million for the fiscal third quarter prior year, with net income of $30 million, or $0.43 per diluted share, compared to $16 million, or $0.23 per diluted share, for the fiscal third quarter ended June 30, 2005.
- Nutraceutical Reports Sales and Income
Company reports net sales for the fiscal 2006 third quarter of $37.0 million compared to $37.2 million for the same quarter prior year, with net income of $3.4 million, or $0.29 diluted earnings per share, compared to $3.2 million, or $0.27 diluted earnings per share, for the same quarter of fiscal 2005.
- Nutraceutical Reports Sales and Income
Company reports net sales for the fiscal 2006 third quarter of $37.0 million compared to $37.2 million for the same quarter prior year, with net income of $3.4 million, or $0.29 diluted earnings per share, compared to $3.2 million, or $0.27 diluted earnings per share, for the same quarter of fiscal 2005.
- Natural Health Trends Appoints Stephanie S. Hayano President and CEO
Company announces the appointment of Stephanie S. Hayano as President and Chief Executive Officer, effective July 31.
- Natural Health Trends Appoints Stephanie S. Hayano President and CEO
Company announces the appointment of Stephanie S. Hayano as President and Chief Executive Officer, effective July 31.
- Natural Health Trends Appoints Stephanie S. Hayano President and CEO
Company announces the appointment of Stephanie S. Hayano as President and Chief Executive Officer, effective July 31.
- Natural Health Trends Appoints Stephanie S. Hayano President and CEO
Company announces the appointment of Stephanie S. Hayano as President and Chief Executive Officer, effective July 31.
- GNC Corporation Files Registration Statement With SEC for IPO
Company announces it filed an amended registration statement with the Securities and Exchange Commission for the initial public offering of its common stock. A total of 23,530,000 shares of common stock are to be sold in the offering, with approximately 9.4 million new shares to be offered by GNC and approximately 14.1 million shares to be sold by its principal stockholder.
- GNC Corporation Files Registration Statement With SEC for IPO
Company announces it filed an amended registration statement with the Securities and Exchange Commission for the initial public offering of its common stock. A total of 23,530,000 shares of common stock are to be sold in the offering, with approximately 9.4 million new shares to be offered by GNC and approximately 14.1 million shares to be sold by its principal stockholder.
- Whole Foods Market Reports Third Quarter Results
Company reported that sales increased 18% to $1.3 billion driven by 14% weighted average square footage growth and 9.9% comparable store sales growth, while net income increased 33% to $53.9 million, and diluted earnings per share increased 27% to $0.37.
- Whole Foods Market Reports Third Quarter Results
Company reported that sales increased 18% to $1.3 billion driven by 14% weighted average square footage growth and 9.9% comparable store sales growth, while net income increased 33% to $53.9 million, and diluted earnings per share increased 27% to $0.37.
- Nu Skin Enterprises Receives Direct Selling Authorization in Mainland China
Company has received approval from the Chinese Ministry of Commerce to commence direct selling activities in Mainland China.
- Nu Skin Enterprises Receives Direct Selling Authorization in Mainland China
Company has received approval from the Chinese Ministry of Commerce to commence direct selling activities in Mainland China.
- Nu Skin Enterprises Reports Second-Quarter 2006 Results
Company reports revenue of $284.1 million, compared to $310.1 million for the prior-year period, with net income and earnings per share for the quarter of $14.1 million and $0.20, respectively, compared to net income of $22.8 million and earnings per share of $0.32 for the same period in 2005.
- Nu Skin Enterprises Reports Second-Quarter 2006 Results
Company reports revenue of $284.1 million, compared to $310.1 million for the prior-year period, with net income and earnings per share for the quarter of $14.1 million and $0.20, respectively, compared to net income of $22.8 million and earnings per share of $0.32 for the same period in 2005.
- Peter Vitulli Selected as CEO of Sciona, Inc.
Peter Vitulli has been appointed President and Chief Executive Officer of Sciona, Inc, a supplier of direct-to-consumer DNA testing for lifestyle and nutritional guidance.
- Peter Vitulli Selected as CEO of Sciona, Inc.
Peter Vitulli has been appointed President and Chief Executive Officer of Sciona, Inc, a supplier of direct-to-consumer DNA testing for lifestyle and nutritional guidance.
- Peter Vitulli Selected as CEO of Sciona, Inc.
Peter Vitulli has been appointed President and Chief Executive Officer of Sciona, Inc, a supplier of direct-to-consumer DNA testing for lifestyle and nutritional guidance.
- Peter Vitulli Selected as CEO of Sciona, Inc.
Peter Vitulli has been appointed President and Chief Executive Officer of Sciona, Inc, a supplier of direct-to-consumer DNA testing for lifestyle and nutritional guidance.
- Balchem Announces Second Quarter Earnings
Company reports net sales of $25.1 million versus $19.5 million the prior year, as the sales of the Encapsulated/Nutritional Products segment were a record $10.5 million, an increase of 55.3% from the prior year comparable quarter.
- Balchem Announces Second Quarter Earnings
Company reports net sales of $25.1 million versus $19.5 million the prior year, as the sales of the Encapsulated/Nutritional Products segment were a record $10.5 million, an increase of 55.3% from the prior year comparable quarter.
- DNP International Reports First Half and Outlook
Company observes adjusted sales increase of over 51%.
- DNP International Reports First Half and Outlook
Company observes adjusted sales increase of over 51%.
- Groupe Danone Reports 2006 first-half results
Company reports like for like sales growth of 8.9%.
- Groupe Danone Reports 2006 first-half results
Company reports like for like sales growth of 8.9%.
- Groupe Danone Reports 2006 first-half results
Company reports like for like sales growth of 8.9%.
- Groupe Danone Reports 2006 first-half results
Company reports like for like sales growth of 8.9%.
- PacificHealth Laboratories, Inc. Announces 2nd Quarter Results
Company reports revenues of $1,747,206 compared to revenues of $2,042,382 in the same period last year, with a net loss of ($26,174), or ($0.00) per share, compared to a net loss of ($407,350), or ($0.04) per share, for the same period last year.
- PacificHealth Laboratories, Inc. Announces 2nd Quarter Results
Company reports revenues of $1,747,206 compared to revenues of $2,042,382 in the same period last year, with a net loss of ($26,174), or ($0.00) per share, compared to a net loss of ($407,350), or ($0.04) per share, for the same period last year.
- Terry Myers Named President-ADM Alliance Nutrition, Inc.
Company has appoiunted Terry Myers, most recently Vice President and General Manager of ADM Alliance Nutrition, Inc., as President.
- Terry Myers Named President-ADM Alliance Nutrition, Inc.
Company has appoiunted Terry Myers, most recently Vice President and General Manager of ADM Alliance Nutrition, Inc., as President.
- Terry Myers Named President-ADM Alliance Nutrition, Inc.
Company has appoiunted Terry Myers, most recently Vice President and General Manager of ADM Alliance Nutrition, Inc., as President.
- Terry Myers Named President-ADM Alliance Nutrition, Inc.
Company has appoiunted Terry Myers, most recently Vice President and General Manager of ADM Alliance Nutrition, Inc., as President.
- Herbalife Ltd. Reports Second-Quarter Results
Company reports second-quarter net sales of $466.0 million, largely attributable to increases in the company's three largest regions, the Americas, Asia Pacific, and Europe, which achieved net sales growth of 39.2 percent, 24.7 percent, and 2.4 percent, respectively, versus the second quarter of 2005. For the quarter ended June 30, 2006, the company reported net income of $36.3 million, or $0.49 per diluted share, compared to $22.8 million, or $0.32 per diluted share in the second quarter of 2005.
- Herbalife Ltd. Reports Second-Quarter Results
Company reports second-quarter net sales of $466.0 million, largely attributable to increases in the company's three largest regions, the Americas, Asia Pacific, and Europe, which achieved net sales growth of 39.2 percent, 24.7 percent, and 2.4 percent, respectively, versus the second quarter of 2005. For the quarter ended June 30, 2006, the company reported net income of $36.3 million, or $0.49 per diluted share, compared to $22.8 million, or $0.32 per diluted share in the second quarter of 2005.
- Wild Oats Markets, Inc. Reports Second Quarter and First Half 2006 Results
Company reports net sales of $296.6 million, up 4.2 percent compared with $284.6 million in the second quarter of 2005, with net income of $4.9 million, or $0.16 per diluted share, compared with net income of $0.9 million, or $0.03 per diluted share, in the same period last year.
- Wild Oats Markets, Inc. Reports Second Quarter and First Half 2006 Results
Company reports net sales of $296.6 million, up 4.2 percent compared with $284.6 million in the second quarter of 2005, with net income of $4.9 million, or $0.16 per diluted share, compared with net income of $0.9 million, or $0.03 per diluted share, in the same period last year.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- Burcon enters into material transfer agreements Puratein(R) and Supertein(TM) to be tested by food & beverage makers
Company announces that it has entered into material transfer agreements with some of the world's foremost food and beverage companies, enabling the company to provide samples of Burcon's proteins; Puratein(R) and Supertein(TM) to food and beverage companies for testing while protecting certain intellectual property interests of all of the parties involved.
- SunOpta Announces Second Quarter Results
Company reports revenues of $155,745,000 compared to $102,858,000 in the second quarter of the prior year, with net earnings of $4,343,000 or $0.08 per diluted common share compared to $3,307,000 or $0.06 per diluted common share in the prior year.
- SunOpta Announces Second Quarter Results
Company reports revenues of $155,745,000 compared to $102,858,000 in the second quarter of the prior year, with net earnings of $4,343,000 or $0.08 per diluted common share compared to $3,307,000 or $0.06 per diluted common share in the prior year.
- SunOpta Announces Second Quarter Results
Company reports revenues of $155,745,000 compared to $102,858,000 in the second quarter of the prior year, with net earnings of $4,343,000 or $0.08 per diluted common share compared to $3,307,000 or $0.06 per diluted common share in the prior year.
- GNC Corporation Reports Second Quarter 2006 Financial Results
Company reports revenues of $382.8 million for the quarter, a 14.8% increase over the same quarter in 2005, with net income of $13.1 million compared to $7.1 million in the second quarter of 2005.
- GNC Corporation Reports Second Quarter 2006 Financial Results
Company reports revenues of $382.8 million for the quarter, a 14.8% increase over the same quarter in 2005, with net income of $13.1 million compared to $7.1 million in the second quarter of 2005.
- Hansen Natural Reports Record Second Quarter Sales and Profits
Company reports net sales of $156.0 million compared to $85.4 million a year ago, as Net income for the second quarter increased 85.0 percent to $28.2 million, or $0.28 per diluted share on a post-split basis ($1.14 per diluted share on a pre-split basis), from $15.2 million, or $0.16 per diluted share on a post-split basis ($0.63 per diluted share on a pre-split basis), last year.
- Hansen Natural Reports Record Second Quarter Sales and Profits
Company reports net sales of $156.0 million compared to $85.4 million a year ago, as Net income for the second quarter increased 85.0 percent to $28.2 million, or $0.28 per diluted share on a post-split basis ($1.14 per diluted share on a pre-split basis), from $15.2 million, or $0.16 per diluted share on a post-split basis ($0.63 per diluted share on a pre-split basis), last year.
- Reliv International, Inc. Reports Second Quarter Results
Company reports net sales of $27.8 million, down 2.4 percent from $28.5 million in the second quarter of 2005. with net income of $1.62 million, down 18 percent from $1.98 million in the same quarter of last year.
- Reliv International, Inc. Reports Second Quarter Results
Company reports net sales of $27.8 million, down 2.4 percent from $28.5 million in the second quarter of 2005. with net income of $1.62 million, down 18 percent from $1.98 million in the same quarter of last year.
- Leiner Health Products Reports First Quarter 2007 Results
Company reports net sales of $163.9 million compared to $145.6 million for the same period in fiscal 2006, with net income of $2.0 million for the quarter, compared to net loss of $4.2 million for the same period in fiscal 2006.
- Leiner Health Products Reports First Quarter 2007 Results
Company reports net sales of $163.9 million compared to $145.6 million for the same period in fiscal 2006, with net income of $2.0 million for the quarter, compared to net loss of $4.2 million for the same period in fiscal 2006.
- Martek and Hain Celestial Sign Exclusive Supply Agreement for Infant Formula Products
Martek Biosciences Corporation and The Hain Celestial Group, Inc. have announced that they have entered into a license and supply agreement whereby Martek will serve as the exclusive DHA and ARA supplier for all Hain Celestial infant formula products in the United States. The companies also announced that they are in discussions regarding the potential expansion of this relationship into other food and beverage products.
- Martek and Hain Celestial Sign Exclusive Supply Agreement for Infant Formula Products
Martek Biosciences Corporation and The Hain Celestial Group, Inc. have announced that they have entered into a license and supply agreement whereby Martek will serve as the exclusive DHA and ARA supplier for all Hain Celestial infant formula products in the United States. The companies also announced that they are in discussions regarding the potential expansion of this relationship into other food and beverage products.
- Allergy Research Group, Inc. Reports Second Quarter Results
Company reports revenues of $3,996,496 for the quarter, compared to $3,981,676 for the same period last year, with net earnings of $257,856 for FY06 Q2 versus $324,710 for FY05 Q2.
- Allergy Research Group, Inc. Reports Second Quarter Results
Company reports revenues of $3,996,496 for the quarter, compared to $3,981,676 for the same period last year, with net earnings of $257,856 for FY06 Q2 versus $324,710 for FY05 Q2.
- Atrium Reports on Second Quarter 2006
Company reports revenues of US$74.3 million for the quarter compared to US$50.3 million for the corresponding quarter in 2005, as net earnings increased 59% to US$6.3 million for the quarter, compared to US$4.0 million for the same quarter last year. Revenues from the Health & Nutrition Division rose 297%.
- Atrium Reports on Second Quarter 2006
Company reports revenues of US$74.3 million for the quarter compared to US$50.3 million for the corresponding quarter in 2005, as net earnings increased 59% to US$6.3 million for the quarter, compared to US$4.0 million for the same quarter last year. Revenues from the Health & Nutrition Division rose 297%.
- Atrium Reports on Second Quarter 2006
Company reports revenues of US$74.3 million for the quarter compared to US$50.3 million for the corresponding quarter in 2005, as net earnings increased 59% to US$6.3 million for the quarter, compared to US$4.0 million for the same quarter last year. Revenues from the Health & Nutrition Division rose 297%.
- Galaxy Nutritional Foods Announces New Directors
Company announces appointment of Mr. Peter J. Jungsberger and Mr. Robert S. Mohel, C.P.A. to its Board of Directors.
- Galaxy Nutritional Foods Announces New Directors
Company announces appointment of Mr. Peter J. Jungsberger and Mr. Robert S. Mohel, C.P.A. to its Board of Directors.
- Galaxy Nutritional Foods Announces New Directors
Company announces appointment of Mr. Peter J. Jungsberger and Mr. Robert S. Mohel, C.P.A. to its Board of Directors.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Edison, New Jersey, August 2nd 2006 – Carotech Inc. announces that it has today entered into an exclusive license agreement with Metagenics, Inc. for the commercialization of Tocomin® SupraBioTM – a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel of distribution in North America (the 'Agreement').
Tocotrienols are a form of vitamin E found in minimal concentrations in plants that have been suggested in scientific studies to offer neuro-protective benefits. Most fat-soluble phytonutrients and antioxidants are poorly absorbed, which results in poor bioavailability. Thus consumers are not getting the optimal benefits, or it takes a longer period of supplementation to see the associated health effects.
Responding to demands from customers worldwide, Carotech embarked on an extensive, 3-year research and development effort to add value and develop novel delivery systems for optimal absorption of tocotrienols. Carotech’s main objective is to offer customers a system that ensures maximum absorption of tocotrienols to reach a therapeutic level at a lower dosage.
Carotech, the leading and largest producer of tocotrienols in the world, was granted a US patent for a unique, bio-enhanced, natural, full-spectrum palm tocotrienol complex that guarantees an increase in blood plasma absorption of tocotrienols by an average of 250% when compared to regular tocotrienol oil extract.
Carotech will collaborate with Metagenics to formulate new and unique products with Tocomin® SupraBioTM, as well as to establish the best commercialization strategy for introducing this novel tocotrienol complex to the healthcare practitioner channel of distribution in North America. The first Metagenics formula featuring Tocomin® SupraBioTM will be a neurological support product for healthy brain function slated for a Fall 2006 launch.
Metagenics, a privately held company, was founded in 1983 with the mission to help patients achieve their genetic potential through targeted nutrition. As the leading developer and manufacturer of natural, science-based nutraceuticals, Metagenics markets its products to healthcare practitioners as innovative approaches to leading health issues.
The Agreement provides Metagenics with the exclusive right to market Tocomin® SupraBioTM to healthcare professionals, with an option to extend this exclusivity subject to Metagenics’ achievement of certain performance criteria.
“This agreement with Metagenics is of great significance to Carotech in that it recognizes the commercial potential of Tocomin® SupraBioTM in the North American healthcare practitioner market. Metagenics will be among the first in the market with this patented bio-enhanced tocotrienol system. We definitely look forward to collaborating with Metagenics, a reputable and experienced nutraceutical company and an ideal long-term strategic partner,” said WH Leong, Vice President, Carotech Inc.
“At Metagenics, we evaluate new ingredients carefully using an in-depth evaluation process that recognizes several aspects of a product, including safety and efficacy,” said Dr. Deanna Minich, Director of Technology and Program Integration at Metagenics, Inc. “Carotech’s Tocamin® SupraBio™ is a superior source of tocotrienols and has been well-tested in several studies for its ability to protect nerve cells. We look forward to providing our healthcare practitioner customers with this high quality ingredient.”
About Carotech Inc.
Carotech Inc. is a wholly owned subsidiary of Carotech Bhd, Malaysia. Carotech, a public listed company in Malaysia (Malaysian Securities Exchange Board under the high-technology / high growth, MESDAQ Board), is the largest producer of tocotrienol in the world via its patented technology. Carotech Bhd is a subsidiary of Hovid Bhd., one of the largest GMP-certified pharmaceutical companies in Malaysia (www.hovid.com).
Tocomin® and Tocomin® SupraBioTM are registered trademarks of Carotech Inc. and protected by US Patent Nos : 5,157,132 and 6,596,306. www.carotech.net
About Metagenics, Inc.
Metagenics, Inc. is a leading developer and manufacturer of science-based nutraceuticals sold to healthcare practitioners worldwide as approaches to leading health concerns. The company is headquartered in San Clemente, Calif., with manufacturing and multiple research facilities located in Gig Harbor, Wash.—including its MetaProteomics® Nutrigenomics Research Center and its Functional Medicine Research CenterSM for human clinical research. Metagenics holds multiple proprietary formula patents and produces over 400 research-based products to optimize health. The company demonstrates its commitment to purity and quality through its certifications for Good Manufacturing Practices (GMP) from the NNFA, NSF International, and TGA. For more information about Metagenics, please visit the company’s Web site at www.metagenics.com.
|